Clinical Trials in Salt Lake City

Showing 9121-9140 of 12,670 trials

An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor

NCT01231568

The study is designed to evaluate the effects of a high fat meal on the pharmacokinetics of 150 mg of GSK2118436, as well as the effects of particle size on the relative bioavailability of GSK2118436.

Cancer

GlaxoSmithKline28 participantsStarted Oct 2010

Scottsdale, Arizona, United States • Detroit, Michigan, United States • Nashville, Tennessee, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

NCT01632904

The purpose of the RELIEF study is to compare symptoms in polycythemia vera (PV) subjects treated with ruxolitinib versus subjects treated with hydroxyurea (HU) as measured by the percent of subjects who achieve a clinically meaningful symptom improvement (ie, total symptom score reduction of ≥ 50% reduction) at Week 16 compared to Baseline. The study is also designed to demonstrate that these responses are durable with continued treatment.

Polycythemia Vera

Incyte Corporation110 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Burbank, California, United States +67 more locations

An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

Find Trials by Condition in Salt Lake City

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Safety Escalating Repeat IV, in Stroke Patients

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

VEG111485: A QTc Study of Pazopanib

Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma

A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)

Extended Follow-Up After Islet Transplantation in T1D

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Clinical Evaluation of Patients With X-linked Retinoschisis

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight